Reading Time: 3 minutesResults of a recent poll suggest that the UK public is incredibly supportive of healthcare research within the NHS. These results will now be used
Reading Time: < 1 minuteI’m glad to finally announce that UK recruitment for the dexpramipexole clinical trial is now open! So far, we are aware that Liverpool has opened
Reading Time: 2 minutesWould it ever cross your mind that the relative lengths of your fingers might be related to the durability of your motor neurones? Probably not
Reading Time: 2 minutesWe organise the International Symposium on ALS/MND every year, and this year, the symposium will be going ‘down under’ to Sydney Australia on 30 November
Reading Time: 2 minutesWe have been made aware that there’s a new kid on the block in terms of unproven treatments, which is a new route of administration
Reading Time: < 1 minuteIn the past year, our blog has been viewed nearly 16,000 times. We’ve written 97 articles to take people behind the scenes of MND research,
Reading Time: < 1 minuteWe’re aware that thing’s may seem quiet in terms of ‘big’ MND research moments… almost too quiet… Well, today, the pharmaceutical companies Biogen Idec and Knopp Biosciences announced
Reading Time: < 1 minuteAs we’ve mentioned in previous posts, our current research grants round is our biggest yet with 19 full applications being reviewed by our research advisory
Reading Time: 2 minutesForm filling is tedious. For those of us of a certain age (I’m not saying any more!) online form filling is even more stressful. So recently,
Reading Time: 2 minutesAn unproven treatment called ‘Spirulina’, which is a type of blue-green algae, has recently been investigated by ALSUntangled*. They concluded that there is no evidence